Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Krystof

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 1990
Hypoxyradiotherapy of uterine cervix cancer to decrease of acute side-effects and treatment complicationsT Tacev, A Vacek, V Strnad, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 1, 2021
Evaluation of Novel Substituted Furopyridines as Inhibitors of Protein Kinases Related to Tau Pathology in Alzheimer´s DiseaseN Schade, P Koch, F Ansideri, et al.
General Physiology and Biophysics|December 8, 2007
Evaluation of novel microtubules interfering agents myoseverin, tubulyzine and E2GG in primary cultures of rat hepatocytesZ Dvorák, M Modrianský, J Vrba, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 1990
Tumor response and treatment complications in radiotherapy of localized prostate cancerV Strnad, T Tacev, B Prokes, et al.
Journal of Inorganic Biochemistry|May 2, 2001
Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure ofZ Trávnícek, M Malon, Z Sindelál, et al.
Czechoslovak Medicine|January 1, 1982
Carcinoma cervicis uteri. Long-term follow-up therapeutic resultsB Ptácková, F Kucera, A Caha, et al.
Czechoslovak Medicine|January 1, 1981
Use of 42 MeV betatron bremsstrahlung irradiation in the therapy combined with radium in carcinoma of the cervixT Tacev, V Krystof, V Spurný, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic routeZ Chmela, J Veselý, K Lemr, et al.
Cellular and Molecular Life Sciences : CMLS|July 9, 2005
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitorV Krystof, I W McNae, M D Walkinshaw, et al.
Leukemia|March 16, 2002
Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinasesK Vermeulen, M Strnad, V Krystof, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 1990
Hypoxyradiotherapy of uterine cervix cancer to decrease of acute side-effects and treatment complicationsT Tacev, A Vacek, V Strnad, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 1, 2021
Evaluation of Novel Substituted Furopyridines as Inhibitors of Protein Kinases Related to Tau Pathology in Alzheimer´s DiseaseN Schade, P Koch, F Ansideri, et al.
General Physiology and Biophysics|December 8, 2007
Evaluation of novel microtubules interfering agents myoseverin, tubulyzine and E2GG in primary cultures of rat hepatocytesZ Dvorák, M Modrianský, J Vrba, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 1990
Tumor response and treatment complications in radiotherapy of localized prostate cancerV Strnad, T Tacev, B Prokes, et al.
Journal of Inorganic Biochemistry|May 2, 2001
Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure ofZ Trávnícek, M Malon, Z Sindelál, et al.
Czechoslovak Medicine|January 1, 1982
Carcinoma cervicis uteri. Long-term follow-up therapeutic resultsB Ptácková, F Kucera, A Caha, et al.
Czechoslovak Medicine|January 1, 1981
Use of 42 MeV betatron bremsstrahlung irradiation in the therapy combined with radium in carcinoma of the cervixT Tacev, V Krystof, V Spurný, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic routeZ Chmela, J Veselý, K Lemr, et al.
Cellular and Molecular Life Sciences : CMLS|July 9, 2005
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitorV Krystof, I W McNae, M D Walkinshaw, et al.
Leukemia|March 16, 2002
Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinasesK Vermeulen, M Strnad, V Krystof, et al.
Pageof 2